PNC Financial Services Group
GTBP icon

PNC Financial Services Group’s GT Biopharma GTBP Stock Holding History

PNC Financial Services Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Buy
+40,000
New +$16.2K ﹤0.01% 3790

Other funds holding GTBP

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
KP
Kitching Partners Conshohocken, Pennsylvania $116M AUM 16.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return
SWP
Sagespring Wealth Partners Franklin, Tennessee $6.51B AUM 25.32% 1-Year Est. Return
TWP
Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return

PNC Financial Services Group's GTBP Position: Q2 2026 in Review

PNC Financial Services Group opened a new position in GT Biopharma (GTBP) in Q2 2026: 40,000 shares worth $19.6K. The stake represents ﹤0.01% of the portfolio and ranks #3790 among its holdings.

28 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • PNC Financial Services Group held 40,000 shares of GT Biopharma worth $19.6K as of Q2 2026.
  • GT Biopharma was a new PNC Financial Services Group position in Q2 2026.
  • GT Biopharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3790 holding.
  • 28 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.